{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:37:32Z","timestamp":1776760652762,"version":"3.51.2"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,6,1]]},"DOI":"10.1001\/jamadermatol.2020.0559","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T15:54:28Z","timestamp":1586361268000},"page":"631","source":"Crossref","is-referenced-by-count":19,"title":["Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants"],"prefix":"10.1001","volume":"156","author":[{"given":"Jeffrey F.","family":"Scott","sequence":"first","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio"},{"name":"Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin R.","family":"Brough","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin V.","family":"Grigoryan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Muzic","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace Y.","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalynn R. Z.","family":"Conic","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena T.","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry D.","family":"Brewer","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian L.","family":"Baum","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Litzow","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Hogan","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrinal S.","family":"Patnaik","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrukh K.","family":"Hashmi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillard M.","family":"Lazarus","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy S.","family":"Bordeaux","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio"},{"name":"Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl L.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meg R.","family":"Gerstenblith","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio"},{"name":"Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia S.","family":"Lehman","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"13","key":"doi200015r1","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJM199703273361301","article-title":"Solid cancers after bone marrow transplantation.","volume":"336","author":"Curtis","year":"1997","journal-title":"N Engl J Med"},{"issue":"5","key":"doi200015r2","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1182\/blood-2008-05-158782","article-title":"Solid cancers after allogeneic hematopoietic cell transplantation.","volume":"113","author":"Rizzo","year":"2009","journal-title":"Blood"},{"issue":"3","key":"doi200015r3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/bmt.2016.290","article-title":"Aggressive skin cancer in chronic GvHD after allogeneic hematopoietic cell transplantation.","volume":"52","author":"Lehman","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"doi200015r4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1200\/JCO.2005.02.7052","article-title":"Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation.","volume":"24","author":"Leisenring","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"doi200015r5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1667\/RR1469.1","article-title":"Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation.","volume":"171","author":"Schwartz","year":"2009","journal-title":"Radiat Res"},{"issue":"7","key":"doi200015r6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jamadermatol.2015.121","article-title":"Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review.","volume":"151","author":"DePry","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"2","key":"doi200015r7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1001\/jamadermatol.2015.3902","article-title":"Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study.","volume":"152","author":"Omland","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"2","key":"doi200015r8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jaad.2018.01.012","article-title":"Role of graft-versus-host disease in the development of secondary skin cancers in hematopoietic stem cell transplant recipients: a meta-analysis.","volume":"79","author":"Rambhia","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi200015r9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jid.2018.08.025","article-title":"Reduced-intensity conditioning regimens, prior chronic lymphocytic leukemia, and graft-versus-host disease are associated with higher rates of skin cancer after allogeneic hematopoietic stem cell transplantation.","volume":"139","author":"Wu","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"4","key":"doi200015r10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJMra1708701","article-title":"Update on keratinocyte carcinomas.","volume":"379","author":"Nehal","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"doi200015r11","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1158\/1078-0432.CCR-18-1122","article-title":"Keratinocyte carcinomas: current concepts and future research priorities.","volume":"25","author":"Nagarajan","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"4","key":"doi200015r12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jaad.2017.06.032","article-title":"Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation.","volume":"77","author":"Kuklinski","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"doi200015r13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bbmt.2012.09.023","article-title":"Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma.","volume":"19","author":"Krishnan","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"22","key":"doi200015r14","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation.","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"doi200015r15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/archderm.1988.01670060015008","article-title":"The validity and practicality of sun-reactive skin types I through VI.","volume":"124","author":"Fitzpatrick","year":"1988","journal-title":"Arch Dermatol"},{"issue":"12","key":"doi200015r16","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1001\/archdermatol.2009.276","article-title":"Incidence of and risk factors for skin cancer after heart transplant.","volume":"145","author":"Brewer","year":"2009","journal-title":"Arch Dermatol"},{"issue":"12","key":"doi200015r17","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/tri.v32.12","article-title":"Predicting skin cancer in organ transplant recipients: development of the SUNTRAC screening tool using data from a multicenter cohort study.","volume":"32","author":"Jambusaria-Pahlajani","year":"2019","journal-title":"Transpl Int"},{"issue":"5","key":"doi200015r18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.36740\/WLek201905118","article-title":"Prognostic model of skin cancer risk assessment.","volume":"72","author":"Oshyvalova","year":"2019","journal-title":"Wiad Lek"},{"issue":"12","key":"doi200015r19","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1016\/j.jid.2018.03.1528","article-title":"A prediction tool to facilitate risk-stratified screening for squamous cell skin cancer.","volume":"138","author":"Wang","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"4","key":"doi200015r20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/ijc.v125:4","article-title":"Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.","volume":"125","author":"Nan","year":"2009","journal-title":"Int J Cancer"},{"issue":"4","key":"doi200015r21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jaad.2014.05.023","article-title":"Self-reported pigmentary phenotypes and race are significant but incomplete predictors of Fitzpatrick skin phototype in an ethnically diverse population.","volume":"71","author":"He","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"doi200015r22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jaad.2012.09.030","article-title":"Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation.","volume":"68","author":"Gogia","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"doi200015r23","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1002\/cncr.v115:11","article-title":"Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"issue":"4","key":"doi200015r24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s40257-018-0348-7","article-title":"Field cancerization therapies for management of actinic keratosis: a narrative review.","volume":"19","author":"Jetter","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"11","key":"doi200015r25","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/jdv.13699","article-title":"Histopathology and reflectance confocal microscopy features of photodamaged skin and actinic keratosis.","volume":"30","author":"Tan","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"24","key":"doi200015r26","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1001\/jama.1992.03480240067036","article-title":"Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer.","volume":"267","author":"Karagas","year":"1992","journal-title":"JAMA"},{"issue":"4","key":"doi200015r27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jamadermatol.2014.3307","article-title":"Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.","volume":"151","author":"Wehner","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"10","key":"doi200015r28","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1056\/NEJMoa1811850","article-title":"Randomized trial of four treatment approaches for actinic keratosis.","volume":"380","author":"Jansen","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"doi200015r29","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1182\/blood-2004-09-3411","article-title":"Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study.","volume":"105","author":"Curtis","year":"2005","journal-title":"Blood"},{"issue":"3","key":"doi200015r30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States.","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"10","key":"doi200015r31","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/ddg.12649","article-title":"Squamous cell carcinomas in chronic venous leg ulcers: data of the German Marjolin Registry and review.","volume":"13","author":"Reich-Schupke","year":"2015","journal-title":"J Deutsch Dermatol Gesellschaft"},{"issue":"1","key":"doi200015r32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jid.2018.06.185","article-title":"Chronic inflammation promotes skin carcinogenesis in cancer-prone discoid lupus erythematosus.","volume":"139","author":"Zaalberg","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"11","key":"doi200015r33","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.bbmt.2014.09.004","article-title":"Second malignancies after allogeneic stem cell transplantation with reduced-intensity conditioning: is the incidence reduced?","volume":"20","author":"Shimoni","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"doi200015r34","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.bbmt.2014.07.009","article-title":"Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.","volume":"20","author":"Ringd\u00e9n","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"doi200015r35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/tid.2015.17.issue-2","article-title":"Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.","volume":"17","author":"Wojenski","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"doi200015r36","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/cid\/cit940","article-title":"Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients.","volume":"58","author":"Williams","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"doi200015r37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/tid.2013.15.issue-4","article-title":"Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart\/lung transplant patients.","volume":"15","author":"McLaughlin","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"doi200015r38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.14366\/usg.16045","article-title":"Logistic LASSO regression for the diagnosis of breast cancer using clinical demographic data and the BI-RADS lexicon for ultrasonography.","volume":"37","author":"Kim","year":"2018","journal-title":"Ultrasonography"},{"issue":"8","key":"doi200015r39","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/bmt.2015.63","article-title":"Secondary solid cancer screening following hematopoietic cell transplantation.","volume":"50","author":"Inamoto","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"doi200015r40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5144\/1658-3876.2012.1","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.","volume":"5","author":"Majhail","year":"2012","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"12","key":"doi200015r41","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1001\/archderm.136.12.1524","article-title":"Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.","volume":"136","author":"Marcil","year":"2000","journal-title":"Arch Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2763685\/jamadermatology_scott_2020_oi_200015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T17:45:54Z","timestamp":1722707154000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2763685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.0559","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,1]]}}}